Pharmacy-managed program for home treatment of deep vein thrombosis with enoxaparin

American Journal of Health-System Pharmacy

Volumn 54, Issue 17, 1997, Pages 1968-1972

  Dedden, Phil ^a   Chang, Barbara ^c   Nagel, Dennis ^b  

^a KAISER FOUNDATION HOSPITAL   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c NONE

Author keywords

Administration; Anticoagulants; Dosage; Drug administration; Enoxaparin sodium; Health care; Health maintenance organizations; Pharmaceutical services; Pharmacists, institutional; Pharmacy, institutional; Quality assurance; Tests, laboratory; Thrombophlebtis; Warfarin

Indexed keywords

ENOXAPARIN; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; DEEP VEIN THROMBOSIS; DRUG SELF ADMINISTRATION; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030868326     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/54.17.1968     Document Type: Article

References (11)

1. Hull RD, Pineo GF. Low molecular weight heparin treatment of venous thromboembolism. Prog Cardiovasc Dis. 1994; 37:71-8.
2. Wragge TM. Prevention and treatment of venous thromboembolism. Pharm Times. 1994; 60(Jun suppl):42-52.
3. Levine M, Gent M, Hirsh J et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996; 334:677-81.
4. Koopman MMW, Prandoni P, Piovella F et al. for the Tasman Study Group. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med. 1996; 334:682-7.
5. Schafer AI. Low-molecular-weight heparin - an opportunity for home treatment of venous thrombosis. N Engl J Med. 1996; 334:724-5.
6. Vitoux J-F, Flessinger J-N, Roncato M et al. Long-term treatment of acute deep venous thrombosis with low-molecular-weight heparin derivative. JAMA. 1988; 259:1180-1. Letter.
7. Huet Y, Janvier G, Bendriss PH et al. Treatment of established venous thromboembolism with enoxaparin: preliminary report. Acta Chir Scand Suppl. 1990; 556:116-20.
8. Janvier G, Freyburger G, Winnock S et al. An open trial of enoxaparin in the treatment of deep vein thrombosis of the leg. Haemostasis. 1991; 21:161-8.
9. Simonneau G, Charbonnier B, Decousus H et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis. Arch Intern Med. 1993; 153:1541-6.
10. Saya FG, Coleman LT, Martinoff JT. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol. Am J Hosp Pharm. 1985; 42:1965-9.
11. Leizorovicz A, Simonneau G, Decousus H et al. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. BMJ. 1994; 309:299-304.